The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A proof-of-concept formative trial evaluating the interest of multiple connected devices for the early detection of hand-foot skin reactions in patients treated with regorafenib therapy (FACET).
 
Romain Coriat
Consulting or Advisory Role - Bayer
Speakers' Bureau - Amgen; Bayer; Novartis/Ipsen
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Pierre Fabre
 
Vincent Sibaud
Honoraria - Bayer; Bristol-Myers Squibb; Incyte; Novartis; Pierre Fabre
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Incyte; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Incyte; Novartis; Pierre Fabre
 
Emmanuelle Dochy
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
 
Thibaut Leturgez
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
 
Pierre Arvis
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
 
Michael Kremliovsky
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
 
John A. Reeves
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Mario Di Palma
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Novartis; Sandoz
Speakers' Bureau - Amgen; Kyowa Kirin; MSD
Research Funding - Bayer; Fresenius; Pierre Fabre; Sandoz
Travel, Accommodations, Expenses - Novartis; Pfizer